Pharmacy in Focus: Navigating GLP-1 demand, cost, and sustainability

With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.

March 25, 25

Targeting GLP-1 users with behavioral health support

Learn about the behavioral health considerations that employers should be mindful of when it comes to GLP-1 users.

Douglas Nemecek, MD, MBA, June 12, 24

Evernorth chief bullish on driving affordability through biosimilars and access through guided care

May 08, 24

Keeping member health on track: A snapshot of the PBM’s clinical expertise

Express Scripts is helping patients understand and manage their conditions through comprehensive disease management.

April 19, 24

What’s on the horizon for nonalcoholic steatohepatitis (NASH) treatment?

The future of NASH treatment is more promising than ever with improved methods for diagnosis and new drugs in development.

Gail Bridges, PharmD, March 11, 24